<html><body><div style="color:#000; background-color:#fff; font-family:HelveticaNeue, Helvetica Neue, Helvetica, Arial, Lucida Grande, sans-serif;font-size:12pt">Dear All,<br>Dr Modabber you should well remember that in the trials in Iran we had a degree of LST conversion in individuals who were originally LST negative (no response to leishmanin; no induration and no erythema), the control group received BCG, and a percent of them converted to LST positive.<br>All the best Ali <br><div><span><br></span></div><div> </div><div>Dr Ali Khamesipour</div><div style="display: block;" class="yahoo_quoted"> <br> <br> <div style="font-family: HelveticaNeue, Helvetica Neue, Helvetica, Arial, Lucida Grande, sans-serif; font-size: 12pt;"> <div style="font-family: HelveticaNeue, Helvetica Neue, Helvetica, Arial, Lucida Grande, sans-serif; font-size: 12pt;"> <div dir="ltr"> <font size="2" face="Arial"> On Friday, January 10, 2014 11:22 AM, Farrokh Modabber
<fmodabber@dndi.org> wrote:<br> </font> </div> <div class="y_msg_container"><div id="yiv1557946293">
<style><!--
#yiv1557946293
_filtered #yiv1557946293 {font-family:Calibri;panose-1:2 15 5 2 2 2 4 3 2 4;}
#yiv1557946293
#yiv1557946293 p.yiv1557946293MsoNormal, #yiv1557946293 li.yiv1557946293MsoNormal, #yiv1557946293 div.yiv1557946293MsoNormal
{margin:0in;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri", "sans-serif";}
#yiv1557946293 a:link, #yiv1557946293 span.yiv1557946293MsoHyperlink
{color:blue;text-decoration:underline;}
#yiv1557946293 a:visited, #yiv1557946293 span.yiv1557946293MsoHyperlinkFollowed
{color:purple;text-decoration:underline;}
#yiv1557946293 span.yiv1557946293EmailStyle17
{font-family:"Calibri", "sans-serif";color:windowtext;}
#yiv1557946293 .yiv1557946293MsoChpDefault
{font-family:"Calibri", "sans-serif";}
_filtered #yiv1557946293 {margin:70.85pt 70.85pt 70.85pt 70.85pt;}
#yiv1557946293 div.yiv1557946293WordSection1
{}
--></style>
<div>
<div class="yiv1557946293WordSection1">
<div class="yiv1557946293MsoNormal">Dear Colleagues,</div>
<div class="yiv1557946293MsoNormal">I recall from Prof. Mayrinks studies, that BCG vaccination may convert leishmanin skin test in some volunteers who are LST-negative (MST-negative). The reactivity would gradually diminish after a few months. Would appreciate any information
on that and on Prof. Mayrink’s current email address.</div>
<div class="yiv1557946293MsoNormal">Many thanks,</div>
<div class="yiv1557946293MsoNormal">Farrokh Modabber</div>
</div>
<br><br>--<br>
<i> This email was sent by icb.usp.br </i>
</div>
</div><br>_______________________________________________<br>Leish-l mailing list<br><a ymailto="mailto:Leish-l@lineu.icb.usp.br" href="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a><br><a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" target="_blank">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a><br><br>--<br>This email was sent by icb.usp.br<br><br><br></div> </div> </div> </div> </div></body></html>